bladder cancer

Advertisement
Patrick DalyOncology | February 9, 2023
In the BladderPath study, researchers explored staging suspected muscle-invasive bladder cancer (MIBC) with MRI and ...
Read More
DocWire News EditorsOncology | April 22, 2022
Eur Urol Focus. 2022 Apr 18:S2405-4569(22)00078-5. doi: 10.1016/j.euf.2022.04.001. Online ahead of print.ABSTRACTRecent ...
DocWire News EditorsASCO 2021 | April 25, 2023
Evaluating efficacy of a cancer peptide vaccine plus pembrolizumab for locally advanced or metastatic urothelial ...
Rebecca AraujoOncology | April 16, 2021
This week, findings from a clinical trial of children with high-risk Hodgkin lymphoma found the anti-CD30 antibody drug ...
Rebecca AraujoOncology | March 5, 2021
This week, the U.S. Food and Drug Administration (FDA) granted accelerated approval to melphalan flufenamide (melflufen) ...
Kaitlyn D’OnofrioOncology | February 19, 2021
The Food and Drug Administration (FDA) accepted Sesen Bio’s Biologics License Application (BLA) for Vicineum for the ...
Kaitlyn D’OnofrioBreast Cancer News | April 11, 2023
Older patients with breast cancer or bladder cancer may increase their survival by taking aspirin, according to a ...
Rob DillardOncology | September 16, 2020
Bladder cancer patients who smoke have worse outcomes following radical cystectomy, according to a study published in ...
Rob DillardOncology | September 3, 2020
Despite previous studies that indicated that people who use hair dye have an augmented risk of cancer, especially ...
Kerri FitzgeraldOncology | April 17, 2020
The U.S. Food and Drug Administration approved Jelmyto™ (mitomycin gel) to treat low-grade upper tract urothelial ...
Kerri FitzgeraldOncology | July 25, 2022
Exposure to trihalomethanes found in tap water increases the risk of bladder cancer and may be responsible for one in 20 ...
Kaitlyn D’OnofrioOncology | January 9, 2020
The Food and Drug Administration (FDA) granted approval for pembrolizumab—marketed as Keytruda and manufactured by ...
Kerri FitzgeraldOncology | December 20, 2019
The U.S. Food and Drug Administration granted accelerated approval to Padcev™ (enfortumab vedotin-ejfv) for adults ...
DocWire News EditorsASCO 2019 | June 4, 2019
Following failure of Bacillus Calmette-Guerin (BCG) for high-grade non–muscle-invasive bladder cancer (NMIBC), there ...
DocWire News EditorsASCO 2019 | June 4, 2019
Platinum-based chemotherapy for first-line treatment of metastatic urothelial cancer is typically administered for a ...
Kerri FitzgeraldOncology | April 25, 2023
The U.S. Food and Drug Administration (FDA) approved erdafitinib (BALVERSA™) for the treatment of adults with ...
Kerri FitzgeraldCardiology | February 19, 2019
A study published in the European Journal of Cancer Prevention observed that no relevant association between the use ...
Advertisement
Advertisement
Advertisement
Latest News

March 18, 2025